SHR7390: Clinical Trials

2 trials of SHR7390, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow SHR7390: new trials by email Literature Review of SHR7390 trials Research Report on SHR7390

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SHR7390 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
SHR7390 - Metastatic Castration-resistant Prostate Cancer
Phase 2CompletedThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School62020-12-172023-06-13
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
SHR7390, Famitinib, SHR3162 - Breast Cancer, Metastatic Cancer
Phase 2UnknownFudan University3192020-05-012022-07-26

Conditions studied

Breast Neoplasms (1)  ·  Neoplasm Metastasis (1)

Sponsors

Fudan University (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

China (2)

Top investigators

Hongqian Guo (1)  ·  Zhi-Ming Shao (1)

Results publications

PMID 33570247